Paul Geertsema
- Molecular Medicine top 0.5%
- Endocrinology top 2%
- Pharmacology top 5%
- Molecular Biology
- Infectious Diseases top 10%
- Topics
- Antibiotic Resistance in Bacteria (22 papers)Financial Markets and Investment Strategies (9 papers)Antibiotics Pharmacokinetics and Efficacy (8 papers)
- Journals
- Antimicrobial Agents and ChemotherapyJournal of Accounting ResearchJournal of Banking & Finance
- Partner nations
- FranceNew ZealandBelgium
In The Last Decade
Paul Geertsema
52 papers receiving 820 citations
Peers
Comparison fields: 5 of 83
- Molecular Medicine 554
- Endocrinology 175
- Pharmacology 172
- Molecular Biology 168
- Infectious Diseases 165
Countries citing papers authored by Paul Geertsema
This map shows the geographic impact of Paul Geertsema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Geertsema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Geertsema more than expected).
Fields of papers citing papers by Paul Geertsema
This network shows the impact of papers produced by Paul Geertsema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Geertsema. The network helps show where Paul Geertsema may publish in the future.
Co-authorship network of co-authors of Paul Geertsema
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Geertsema. A scholar is included among the top collaborators of Paul Geertsema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Geertsema. Paul Geertsema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 8 | |
| 6 | 5 | |
| 7 | 25 | |
| 8 | 208 | |
| 9 | 136 | |
| 10 | 94 | |
| 11 | 21 | |
| 12 | 15 | |
| 13 | 4 | |
| 14 | 8 | |
| 15 | 91 | |
| 16 | 13 | |
| 17 | 15 | |
| 18 | [Mechanism of enzymatic resistance to beta-lactam antibiotics]. | 4 |
| 19 | Sérodiagnostic des infections respiratoires à Pasteurella multocida | 1 |
| 20 | 8 |
About Paul Geertsema
Paul Geertsema is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Virology, having authored 57 papers that have together received 876 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Financial Markets and Investment Strategies (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). The work is most often cited by research in Molecular Medicine (554 citations), Applied Microbiology and Biotechnology (85 citations) and Endocrinology (175 citations). Paul Geertsema has collaborated with scholars based in France, New Zealand and Belgium. Frequent co-authors include Roger Labia, P Névot, A. Philippon, D. Sirot, El Bachir Chaibi, L Gilly, G. Baranton, D. Postic, Marc V. Assous and A Buré. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Accounting Research and Journal of Banking & Finance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.